This website uses cookies to enhance the user experience.
21st logo
||
TA

Tore Audun Haugo1959

Shareholdings
20
Arrow
0
Double arrow
Norway Business roles
2

Roles

Boards

NameRoleTotal operating incomeTotal equityShares
T
TORE HAUGO
Holder
-
-
-
T
TOKKE TAXISENTRAL DA
Participant with Pro Rata Liability (Shared Liability)
-
-
-
Last update: Apr 13, 2023

Related industries

No related industries

Direct relationships

2

Shares owned by Tore Audun Haugo

NameShare classTotal operating incomeTotal equityShare
T
TAXI TRANSPORT TELEMARK AS
Ordinære aksjer
0
3,047,376
0.58 %
directly < 0.01 %
E
ENSURGE MICROPOWER ASA
Ordinære aksjer
0
59,115,000
< 0.01 %
directly
A
AKER ASA
Ordinære aksjer
0
18,422,000,000
< 0.01 %
directly
I
ININ GROUP AS
Ordinære aksjer
5,569,000
183,328,000
< 0.01 %
directly
O
ORKLA ASA
Ordinære aksjer
71,807,000,000
52,147,000,000
< 0.01 %
directly
M
M VEST WATER AS
Ordinære aksjer
25,970,787
30,232,053
< 0.01 %
directly
S
STOREBRAND ASA
Ordinære aksjer
8,377,000,000
36,130,000,000
< 0.01 %
directly
V
VÅR ENERGI ASA
Ordinære aksjer
8,096,000,000
560,000,000
< 0.01 %
directly
A
AKER HORIZONS ASA
Closed
Ordinære aksjer
0
4,048,000,000
< 0.01 %
directly
H
HERMANA HOLDING ASA
Ordinære aksjer
1,000,000
0
< 0.01 %
directly
C
CAVENDISH HYDROGEN ASA
Ordinære aksjer
373,000
49,728,000
< 0.01 %
directly
N
NORCONSULT ASA
Ordinære aksjer
9,185,000,000
2,531,000,000
< 0.01 %
directly
I
IDEX BIOMETRICS ASA
Ordinære aksjer
256,000
4,020,000
< 0.01 %
directly
N
NEL ASA
Ordinære aksjer
103,455,000
5,445,241,000
< 0.01 %
directly
M
MAGNORA ASA
Ordinære aksjer
134,000,000
0
< 0.01 %
directly
L
LYTIX BIOPHARMA ASA
Ordinære aksjer
0
61,750,000
< 0.01 %
directly
N
NYKODE THERAPEUTICS ASA
Ordinære aksjer
453,000
94,977,000
< 0.01 %
directly
O
ONCOINVENT ASA
Ordinære aksjer
1,909,000
122,658,000
< 0.01 %
directly
T
THOR MEDICAL ASA
Ordinære aksjer
839,000
475,867,000
< 0.01 %
directly
G
GJENSIDIGE FORSIKRING ASA
Ordinære aksjer
-
-
< 0.01 %
directly

Limited to direct ownership positions of 0.5% or more.

Last update: Oct 30, 2026